Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy in the Canadian Longitudinal Study on Aging
Results of this cohort study reveal that epilepsy was associated with new-onset CVEs. Nearly one-third of this association can be explained by EIASMs. These findings should be considered when choosing an antiseizure medication for a person at risk for cardiovascular disease.
Authors
- Nathan A. Shlobin (ORCID: https://orcid.org/0000-0003-2079-6125)
- Roland D. Thijs (ORCID: https://orcid.org/0000-0003-1435-8970)
- Mark R. Keezer (ORCID: https://orcid.org/0000-0002-2807-7347)
- Colin B. Josephson (ORCID: https://orcid.org/0000-0001-7052-1651)
- Charles Deacon
- Jimmy Li (ORCID: https://orcid.org/0000-0002-8386-8897)
- Marie-Pierre Sylvestre
Institutions
- Université de Sherbrooke (CA)
- University of Calgary (CA)
- Leiden University Medical Center (NL)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- UCL Biomedical Research Centre (GB)
- Centre Hospitalier de l’Université de Montréal (CA)
- National Hospital for Neurology and Neurosurgery (GB)
- Stichting Epilepsie Instellingen Nederland (NL)
- Hotchkiss Brain Institute (CA)
- University College London (GB)
- Université de Montréal (CA)
- Columbia University (US)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1001/jamaneurol.2024.3210
- Citations
- 16
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.17